Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iMAP2: Comparison of Two Pertussis Vaccines in Pregnancy
NCT02145624Phase 4Completed
- Sponsor
- UK Health Security Agency
- Start
- Oct 2014
- Primary completion
- Jun 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Adacel Polio and Boostrix Polio in pertussis (3 arms), sponsored by UK Health Security Agency. Primary endpoints: Pertussis Toxin Immunogenicity (IgG Geometric Mean Concentration) at 13 months, Immunogenicity of Pertussis Antigens (IgG Geometric Mean Concentration) at 13 months and 2 more. Started Oct 2014; status: completed.
02
Drugs
Adacel PolioBoostrix Polio
03
Conditions
pertussis
Beyond the preview
Go deeper on NCT02145624.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02145624.